1. Management of quinolone-resistant typhoid osteomyelitis
- Author
-
Darius Armstrong-James, Stephen Morris-Jones, Emily Pollock, Julie Lau Kuen Wing, Alastair McGregor, and Michael Brown
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,business.industry ,medicine.drug_class ,Osteomyelitis ,General Medicine ,Quinolone ,Microbiology ,Anti-Bacterial Agents ,Young Adult ,Internal medicine ,Drug Resistance, Multiple, Bacterial ,medicine ,Quinolines ,Humans ,Female ,Typhoid Fever ,business ,Typhoid osteomyelitis - Abstract
andtrimethoprim-sulfamethoxazole,� whicharetraditionallyfirst-lineagentsfor� thetreatmentofentericfever.�Themultid- rugresistancephenotypehasbecomecom- moninS. typhiand,�toalesserextent,�S. paratyphi� (ParryandThrelfall,� 2008)� and� thishasledtogreaterrelianceonother� agents,�particularlyfluoroquinolones.� Promisingresultswithciprofloxacin� suggestedthatitwasmoreeffectiveinthe� treatmentofuncomplicatedentericfever� inareaswithhighratesofmultidrugresist- ancesalmonellae� (Alametal,� 1995)� and� quinolonesalsohavesignificantlyreduced� failureratescomparedwithsomefirst-line� agentsinentericfevercausedbysuscepti- bleisolates� (Thaveretal,� 2008).� Unfortunately,� overthepastdecade,� iso- lateswithdecreasedciprofloxacinsuscepti- bilityhavebecomemorecommonandare� associatedwithtreatmentfailureand� relapse� (Chuangetal,� 2009).� Atthe� HospitalforTropicalDiseases,� London,� salmonellaewithdecreasedciprofloxacin�
- Published
- 2011